
United States · Financial services startup
Symbiont is a technology company based in New York that specializes in enterprise blockchain solutions for the financial services industry.
Funding reportedLast round: Venture (Round not Specified)
Symbiont is a technology company based in New York that specializes in enterprise blockchain solutions for the financial services industry.
The company focuses on smart contracts and distributed ledger technologies to address complex challenges in global finance. With a team of 51-200 professionals, including capital markets experts and engineers, Symbiont operates on its AssemblyTM blockchain platform. This platform is designed to reduce operational friction in the lifecycle of financial instruments and facilitate secure, real-time data sharing. Symbiont's core offerings include the AssemblyTM Blockchain, which aims to create market efficiencies and drive innovation in financial markets. The company emphasizes fintech services that streamline global finance operations and build infrastructure for future market needs. Its primary target customers are entities within the financial services sector that deal with complex financial instruments and seek operational efficiencies through blockchain technology.
Funding, as reported
From Symbiont's own website: 2 on the team.
What they build
Known for
security measuresincident responsedata protectionsmart contractscybersecurity best practicesrisk profile assessmentsuccessful outcomesholistic cybersecuritysmall business cybersecuritytraining programseducational resourcesinformation technology & servicescomprehensive policiesfinancial servicesregulatory frameworksfinance
Built with from their website
Google Tag ManagerFont AwesomeViewport MetaCAPTCHAGoogle Font APIMicrosoft ExchangeGoogle Cloud reCAPTCHA EnterpriseMicrosoft 365 Apps & ServicesMobile FriendlyOpen Graph
jQueryNicepageGoogle AnalyticsFroala EditorGoogle Analytics 4Amazon AWSMicrosoft Exchange OnlineZoneEdit
Add your raise, your deck and your story, and put Symbiont in front of investors. Or tell us what we have wrong.